• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Volume 8 - Issue 7 - July 2011

Case Report and Brief Review »

Thromboangitis Obliterans Associated with Cannabis Use: A Case Report and Literature Review

By: Jason Q. Alexander, MD,1 Mark X. Ciagne, MD,2 James H. Kong, MD2

Abstract

Background. Thromboangitis obliterans (TAO or Buerger's Disease) is most commonly associated with tobacco exposure. A similar cannabis induced form of thromboangitis obliterans has been suggested in the literature. Unfortunately, most patients reported in the literature with radiologic evidence of thromboangitis obliterans and cannabis exposure are noted to have concomitant exposure to tobacco. This confounds the results and questions the validity of true thromboangitis obliterans secondary to cannabis.

Read the full story »

Original Research »

Lessons Learned from the Case Series of Carotid Artery Stenting in a Community Hospital

By: Mateen F. Abidi, MD,1 Nicolai Mejevoi, MD,1 Marc Cohen, MD,1,2 Bruce Brener, MD,1 Najam Wasty, MD, FACC1 The authors also acknowledge Gail Baker, APN,1 for her efforts and contributions to the research.

Abstract

Background. Carotid artery stenting (CAS) is evolving as a less invasive alternative to carotid endarterectomy (CEA) to treat patients with carotid artery stenosis at high surgical risk. However, little is known about the quality and safety of CAS in a relatively low volume, community hospital setting, especially when used as an alternative to CEA for high-risk surgical candidates. 

Read the full story »

Case Report »

Entrapment of Micropuncture Sheath: A Re-access Complication with a StarClose Vascular Closure Device

By: Kalgi A. Modi, MD, FACC, Aman Mundi, MD, Pratap C. Reddy, MD

Abstract

The majority of interventional procedures require access via the femoral artery. A variety of closure devices have been developed to facilitate access site management and early ambulation. The StarClose™ Vascular Closure System (Abbott Vascular, Abbott Park, Illinois), which features a nitinol clip, has received approval for repuncture and reclosure in patients undergoing percutaneous catheterization procedures. We report a case of entrapment of a micropuncture vascular sheath into a previously placed StarClose™ device and its successful retrieval.

Read the full story »

Vascular Spotlight »

UC Davis Vascular Center Spotlight with Professor David L. Dawson, MD

Tell us about the UC Davis Vascular Center’s interdisciplinary approach to treating peripheral vascular disease.

The UC Davis Vascular Center provides total vascular care. Ours is a multidisciplinary center, integrating the services of all specialists and subspecialists involved in diagnosing and treating any form of blood-vessel disease—from varicose veins to complex vascular disorders. Teams work together during clinic visits and procedures to provide the best care for patients with vascular disease or injury.

Read the full story »

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
  • Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System
    Mon, 05/14/12 - 12:07pm
more »

Clinical Events Calendar

  • EuroPCR 2012
    Tue, 05/15/2012 - Fri, 05/18/2012
    Paris, France
  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications